Carotid Stent Coverage Parameters To Be Sketched At CMS “Town Hall”
This article was originally published in The Gray Sheet
Executive Summary
CMS will decide whether carotid stent coverage criteria should include facility requirements beyond physician participation in manufacturer-sponsored training
You may also be interested in...
Cordis Precise, Guidant Acculink Are First “Approvable” Carotid Stents
Johnson & Johnson/Cordis and Guidant are working to satisfy FDA's remaining conditions for approval of their respective Precise and Acculink carotid stent systems, as outlined in recent "approvable" letters
Cordis Precise, Guidant Acculink Are First “Approvable” Carotid Stents
Johnson & Johnson/Cordis and Guidant are working to satisfy FDA's remaining conditions for approval of their respective Precise and Acculink carotid stent systems, as outlined in recent "approvable" letters
Thoratec’s Nelson Challenges CMS Basis For Setting LVAD Facility Criteria
CMS' criteria for approving facility coverage of "destination" left-ventricular assist device implants are not rooted in scientific evidence, according to Thoratec Cardiovascular Division President Jeff Nelson